altM Raises $10.3 Million for Bio-Chemical Production

CHEMICALS
Whalesbook Logo
AuthorRiya Kapoor|Published at:
altM Raises $10.3 Million for Bio-Chemical Production

Bengaluru-based specialty chemicals startup altM has secured $10.3 million in a Series A funding round. Founded by former Tesla executives, the company converts agricultural waste into industrial materials. The new capital will support its transition from pilot-scale research to full-scale commercial manufacturing.

Bengaluru-based startup altM has announced a $10.3 million Series A funding round, a significant step in its plan to scale the production of bio-derived chemicals. The funding round was led by Rainmatter, the investment arm of Zerodha, and Mela Ventures. Several existing investors, including Omnivore and Theia Ventures, also participated, bringing the company’s total funding to approximately $13.8 million since its inception in 2022.

altM operates in the specialty chemicals sector, focusing on a sustainable business model that converts agricultural residues—such as rice straw and sugarcane bagasse—into high-value industrial inputs. The company’s process breaks down lignocellulosic biomass to create molecules used in various industries, including personal care products like suncare formulations, as well as textiles and electronics. By targeting agricultural waste, the company aims to offer a greener alternative to traditional, fossil-fuel-derived chemical production.

Transitioning to Commercial Production

The fresh capital is earmarked for a critical phase in the startup's lifecycle: moving from pilot-scale production to commercial-scale manufacturing. For chemical startups, this transition is often the most capital-intensive and operationally complex stage. The company, co-founded by former Tesla executives Apoorv Garg and Yugal Raj Jain, has spent the last two years developing its R&D infrastructure. Leadership has indicated that several of their chemical molecules have already reached the demonstration scale, and the current goal is to build out the capacity necessary to meet market demand.

Understanding the Business Model and Risks

While the company’s mission to replace fossil-based chemicals with bio-derived alternatives aligns with global sustainability trends, it faces several operational challenges. First, the startup must prove it can produce these materials at a cost and quality that competes effectively with established, lower-cost fossil-derived chemicals. Investors in the space typically monitor whether these startups can achieve price parity at scale.

Second, the reliability of the supply chain is a key factor. The business model relies on the consistent, high-volume procurement of agricultural biomass. Managing the logistics of collecting crop residue and ensuring consistent quality remains a technical and operational hurdle.

Finally, it is important for investors to note that altM is a privately held startup. It is not currently listed on any stock exchange, and its shares are not available for trading on the NSE or BSE. The company remains in a growth phase, where it must navigate high capital requirements and ongoing competition before establishing a mature, profitable manufacturing operation.

Moving forward, the company's progress will be measured by its ability to commission its commercial plants on time, manage input costs effectively, and secure long-term commercial contracts with manufacturers in the personal care and industrial sectors.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.